BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9874485)

  • 1. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis.
    Wadia N; Pang J; Desai J; Mankodi A; Desai M; Chamberlain S
    Brain; 1998 Dec; 121 ( Pt 12)():2341-55. PubMed ID: 9874485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of five spinocerebellar ataxia type 2 pedigrees in patients with autosomal dominant cerebellar ataxia in Taiwan.
    Hsieh M; Li SY; Tsai CJ; Chen YY; Liu CS; Chang CY; Ro LS; Chen DF; Chen SS; Li C
    Acta Neurol Scand; 1999 Sep; 100(3):189-94. PubMed ID: 10478584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin Card Sorting Test and saccade velocity.
    Gambardella A; Annesi G; Bono F; Spadafora P; Valentino P; Pasqua AA; Mazzei R; Montesanti R; Conforti FL; Oliveri RL; Zappia M; Aguglia U; Quattrone A
    J Neurol; 1998 Oct; 245(10):647-52. PubMed ID: 9776463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics.
    Mizushima K; Watanabe M; Abe K; Aoki M; Itoyama Y; Shizuka M; Okamoto K; Shoji M
    J Neurol Sci; 1998 Apr; 156(2):180-5. PubMed ID: 9588855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-genetic study of type I spinocerebelllar ataxia].
    Svetel M; Culjković B; Sternić N; Dragasević B; Stojković I; Romac S; Kostić VS
    Srp Arh Celok Lek; 1999; 127(5-6):157-62. PubMed ID: 10500422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates.
    Giunti P; Sabbadini G; Sweeney MG; Davis MB; Veneziano L; Mantuano E; Federico A; Plasmati R; Frontali M; Wood NW
    Brain; 1998 Mar; 121 ( Pt 3)():459-67. PubMed ID: 9549522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia.
    Lorenzetti D; Bohlega S; Zoghbi HY
    Neurology; 1997 Oct; 49(4):1009-13. PubMed ID: 9339681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction.
    Storey E; Forrest SM; Shaw JH; Mitchell P; Gardner RJ
    Arch Neurol; 1999 Jan; 56(1):43-50. PubMed ID: 9923760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic studies of spinocerebellar ataxia type 2 in Japanese kindreds.
    Ueyama H; Kumamoto T; Nagao S; Mita S; Uchino M; Tsuda T
    Acta Neurol Scand; 1998 Dec; 98(6):427-32. PubMed ID: 9875622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds.
    Schöls L; Krüger R; Amoiridis G; Przuntek H; Epplen JT; Riess O
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):67-73. PubMed ID: 9436730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1.
    Goldfarb LG; Vasconcelos O; Platonov FA; Lunkes A; Kipnis V; Kononova S; Chabrashvili T; Vladimirtsev VA; Alexeev VP; Gajdusek DC
    Ann Neurol; 1996 Apr; 39(4):500-6. PubMed ID: 8619528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxia type 2 in China: molecular analysis and genotype-phenotype correlation in nine families.
    Zhou YX; Wang GX; Tang BS; Li WD; Wang DA; Lee HS; Sambuughin N; Zhou LS; Tsuji S; Yang BX; Goldfarb LG
    Neurology; 1998 Aug; 51(2):595-8. PubMed ID: 9710044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).
    David G; Dürr A; Stevanin G; Cancel G; Abbas N; Benomar A; Belal S; Lebre AS; Abada-Bendib M; Grid D; Holmberg M; Yahyaoui M; Hentati F; Chkili T; Agid Y; Brice A
    Hum Mol Genet; 1998 Feb; 7(2):165-70. PubMed ID: 9425222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular analysis of a pedigree of southern Italian ancestry with spinocerebellar ataxia type 2.
    Adams C; Starkman S; Pulst SM
    Neurology; 1997 Oct; 49(4):1163-6. PubMed ID: 9339711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype variation correlates with CAG repeat length in SCA2--a study of 28 Japanese patients.
    Sasaki H; Wakisaka A; Sanpei K; Takano H; Igarashi S; Ikeuchi T; Iwabuchi K; Fukazawa T; Hamada T; Yuasa T; Tsuji S; Tashiro K
    J Neurol Sci; 1998 Aug; 159(2):202-8. PubMed ID: 9741408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The phenotype variation correlates with the size of CAG repeat in SCA2].
    Sasaki H; Sanpei K
    Nihon Rinsho; 1999 Apr; 57(4):818-21. PubMed ID: 10222772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion.
    Babovic-Vuksanovic D; Snow K; Patterson MC; Michels VV
    Am J Med Genet; 1998 Oct; 79(5):383-7. PubMed ID: 9779806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds.
    Schöls L; Gispert S; Vorgerd M; Menezes Vieira-Saecker AM; Blanke P; Auburger G; Amoiridis G; Meves S; Epplen JT; Przuntek H; Pulst SM; Riess O
    Arch Neurol; 1997 Sep; 54(9):1073-80. PubMed ID: 9311350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India.
    Sinha KK; Worth PF; Jha DK; Sinha S; Stinton VJ; Davis MB; Wood NW; Sweeney MG; Bhatia KP
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):448-52. PubMed ID: 14966163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation.
    Johansson J; Forsgren L; Sandgren O; Brice A; Holmgren G; Holmberg M
    Hum Mol Genet; 1998 Feb; 7(2):171-6. PubMed ID: 9425223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.